96 related articles for article (PubMed ID: 21942642)
21. Dose-response analysis of effects of tibolone on climacteric symptoms.
Landgren MB; Bennink HJ; Helmond FA; Engelen S
BJOG; 2002 Oct; 109(10):1109-14. PubMed ID: 12387462
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone.
Verheul HA; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):195-204. PubMed ID: 17113982
[TBL] [Abstract][Full Text] [Related]
23. Tibolone and its effects on bone: a review.
Berning B; Bennink HJ; Fauser BC
Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
[TBL] [Abstract][Full Text] [Related]
24. Endometrial effects of tibolone in elderly, osteoporotic women.
Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
[TBL] [Abstract][Full Text] [Related]
25. Tibolone vaginal versus per os administration in the management of post-menopausal symptoms.
Zervoudis S; Iatrakis G; Peitsidis P; Tsikouras P; Galazios G; Liberis V; Navrozoglou I; Ceauşu I; Badiu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):471-7. PubMed ID: 21491823
[TBL] [Abstract][Full Text] [Related]
26. [Our experience in the treatment of climacteric complaints with Livial (Organon)].
Pekhlivanov B; Malinova M; Milchev N
Akush Ginekol (Sofiia); 2001; 40(4):16-7. PubMed ID: 11803863
[TBL] [Abstract][Full Text] [Related]
27. What have we really learned from 'LIBERATE' trial?
Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
[TBL] [Abstract][Full Text] [Related]
28. The influence of tibolone on quality of life in postmenopausal women.
Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
Maturitas; 2002 Jan; 41(1):35-43. PubMed ID: 11809341
[TBL] [Abstract][Full Text] [Related]
29. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
[TBL] [Abstract][Full Text] [Related]
31. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
32. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
35. Tibolone for prevention and treatment of postmenopausal osteoporosis.
Ettinger B
Maturitas; 2007 May; 57(1):35-8. PubMed ID: 17350774
[TBL] [Abstract][Full Text] [Related]
36. [Alternatives to hormone replacement therapy: raloxifene and tibolone].
von Holst T
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):205-9. PubMed ID: 10802895
[TBL] [Abstract][Full Text] [Related]
37. The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
Stuckey BG; Barrett PH; Wagner JM; Hampton RA; Chan DC; Brown SJ; Watts GF
Clin Endocrinol (Oxf); 2010 Oct; 73(4):497-501. PubMed ID: 20560981
[TBL] [Abstract][Full Text] [Related]
38. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
39. [Clinical aspects of Livial in postmenopausal replacement therapy].
Grzechocińska B; Marianowski L
Ginekol Pol; 2002 Mar; 73(3):213-20. PubMed ID: 12092255
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
